Company intelligence / Profile preview

Advance Pharmaceuticals

Holtsville, New York, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Revivify, the flagship product utilizing proprietary SOD soluble fiber technology, has demonstrated improvements in metabolic health, dermatological conditions, and neurological function through preclinical research and over 300 documented case reports. The formulation promotes short-chain fatty acid production, modulates probiotic populations, and reduces oxidative stress biomarkers including malondialdehyde and 8-isoprostane.

Therapeutic areas: ImmunologyEndocrinologyNeurologyDermatologyGastroenterology
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

U.S. Department of Veterans AffairsU.S. Department of DefenseState healthcare programsHealthcare providers, distributors, and retail chains

Beyond the preview

Go deeper on Advance Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advance Pharmaceuticals.

Explore the full profile